كلمة تبسيط في الكيمياء العضوية ..الدواء من مصنع الشجرة الرباني أم من المعمل البشري

كيف يصنع الدواء و هل هناك مصنعا ربانيا شرح مبسط كيفية صناعة الدواء في المعمل و الشجرة   ???? ?? ???????? ??????? ???????? ??????? ?? ?????? ? ??? ?????? ..????? ???? ? ????? ???? ?????? ????? Posted by SeragPsych on Sunday, October 28, 2018

Fear of falling : efficacy of virtual reality associated with serious games in elderly people.

Fear of falling : efficacy of virtual reality associated with serious games in elderly people. Abstract : OBJECTIVE : Fear of falling is defined as an ongoing concern about falling that is not explained by physical examination. Focusing on the psychological dimension of this pathology (phobic reaction to walking), we looked at how virtual reality […]

FDA approved psychoactive medication for Children

Fluoxetine for Pediatric Patients US FDA Approved for Pediatric Use Major depressive disorder (fluoxetine, ages 8 and older) Obsessive compulsive disorder (fluoxetine, ages 7 and older) Bipolar depression [in combination with olanzapine (Symbyax), ages 10 and older] Off-Label for Pediatric Use But Approved in Adults Panic disorder (fluoxetine, fluoxetine weekly) Premenstrual dysphoric disorder (Sarafem) Bulimia […]

Electro-Convulsive therapy : Facts and Myths

As evidence supporting the use of electroconvulsive therapy (ECT) to treat patients with depression and other psychiatric illnesses continues to grow, myths about this treatment persist. In light of these myths, patients might be reluctant to receive ECT. As clinicians, we need to educate patients about the safety and effectiveness of this treatment. Here are […]

CLOZAPINE

Clozapine What’s of Interest: Clozapine REMS and ANC monitoring update Brands Clozaril, Leponex, Versacloz (oral suspension), Fazaclo ODT (oral disintegrating tablet) Class Atypical antipsychotic (serotonin-dopamine antagonist; second-generation antipsychotic; also a mood stabilizer) Approved For: Treatment-resistant schizophrenia   Reduction in risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder     Formulation: Tablet […]

New marijuana-based pharmaceutical drug approved by FDA

What is Epidiolex? Epidiolex is an oral liquid-based drug made from the cannabidiol (CBD) portion of cannabis. Compared to the tetrahydrocannabinol (THC) portion, CBD is not psychoactive, so taking this drug would not result in a high for the user. CBD acts on different parts of the nervous system compared with THC. According to the […]

May 21, 2018   :FDA Approves First Non-Opioid to Treat Opioid Withdrawal Symptoms 

    The US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine, which may lead to relief of autonomic withdrawal symptoms. Loxefidine is not approved for the treatment […]

How to Screen for Sleep Apnea

    To screen for Obstructive Sleep Apnea, we need to check for multiple factors. The STOP-Bang questionnaire looks at these multiple factors. A link to information about the questionnaire is provided below.       1. Snoring Ask the patient and the person who sleeps in the same room. But, many of our patients […]

Risperidone (Risperdal®)

Risperidone (US brand name Risperdal® and generic) is a second-generation (“atypical”) antipsychotic. Here is basic information about this medication. FDA-approved indications 1. Treatment of schizophrenia 2. As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder 3. Treatment of irritability associated with autistic disorder […]

Risperidone long-acting (Risperdal Consta®)

Risperdal Consta® is a long-acting injectable formulation of risperidone, a second-generation (“atypical”) antipsychotic. Here is basic information about this medication. FDA-Approved Indications Schizophrenia Monotherapy for the maintenance treatment of Bipolar I Disorder Adjunctive therapy to lithium or valproate for the maintenance treatment of Bipolar I Disorder. Disadvantages Requires refrigeration Administered every 2 weeks rather than […]

How To Use eBooks In eLearning

        eBooks are portable, printable, and multiplatform-friendly. When they first arrived on the literary scene they were merely electronic copies of the original text. Today, they are fully interactive and immersive, making them a welcome addition to eLearning courses. At a moment’s notice, online learners can download an eBook onto their laptop, tablet, or […]

Maslow Hierarchy for self actualization –هرمية ماسلو لتحقيق الذات –

 وضع ابراهام ماسلو نظرية ارتقاء و نمو النفس الى تحقيق الذات و لم يضع تعريفا دقيقا لتحقيق الذات و لكنه للتبسيط و على وجه العموم هو ان  تصل لمرحلة تبسط فيها رأيك و فكرتك في الوقت الذي تراه بالشكل الذي تراه أمام من تراه  و و تدافع عن فكرتك وتضحى من أجلها و و تبذل الغالي […]

sub-typing of depression in clinical settings

Dr. Adel Serag is a senior consultant psychiatrist in Fakeeh hospital and Senior Consultant and fellow of psychiatry , Institute of psychiatry, Ain Shams University. A review lecture about the sub-typing of depression and how this will affect positively in clinical description and hence probably the medication. The lecture was given April 2015 during 11th […]

Problems of Mental illness Stigma and co-morbidity

Norman Sartorius, M.D., M.A., D.P.M., Ph.D., FRC. Psych. Dr Norman Sartorius, MD, MA, DPM, PhD, FRCPsych, obtained his M.D. in Zagreb (Croatia). He specialized in neurology and psychiatry and subsequently obtained a Masters Degree and a Doctorate in psychology (Ph.D.). He carried out clinical work and research and taught at graduate and postgraduate levels at […]

Long term treatment of Schizophrenia: Dr. Mohamed Swuidan

Dr. Mohammad Alsuwaidan is an assistant professor of psychiatry at both Kuwait University and the University of Toronto, where he is cross-appointed to the divisions of Brain Therapeutics and Philosophy, Humanities and Educational Scholarship. He is the Founding Director of the Mood & Anxiety Disorders Program at Mubarak Al-Kabeer Hospital.     Research review of […]